<scp>ATF3</scp> Within the Interferon Signaling Pathway: A Potential Biomarker for Predicting Pathological Response to Neoadjuvant Chemoimmunotherapy
We established that a subset of interferon signaling pathways, NeoIGS, is closely associated with immunotherapy. Among them, ATF3 is the most critical gene that accurately predicts pathological remission in neoadjuvant chemoimmunotherapy.
Authors
- Taiming Zhang (ORCID: https://orcid.org/0000-0002-0623-652X)
- Yong He (ORCID: https://orcid.org/0000-0002-9404-798X)
- Chao He (ORCID: https://orcid.org/0009-0003-9347-7798)
- Yu Deng (ORCID: https://orcid.org/0000-0001-6328-343X)
- Rui Han (ORCID: https://orcid.org/0000-0003-2612-3570)
- Peng Zhong (ORCID: https://orcid.org/0000-0002-3199-2319)
- Conghua Lu (ORCID: https://orcid.org/0000-0003-3685-4908)
- Daijuan Huang
- Yimin Zhang (ORCID: https://orcid.org/0000-0003-0724-5142)
- Jianghua Li (ORCID: https://orcid.org/0000-0002-9720-9438)
Institutions
- Army Medical University (CN)
- Daping Hospital (CN)
- People's Hospital of Bishan District (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Thoracic Cancer
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1111/1759-7714.70056
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Centre Scientifique et Technique du Bâtiment